Home / BusinessBusinessBloombergBusinessBloomberg·Sep 18, 2026·1 min readImmunology Drugmaker Electra Opens Flat After Upsized US IPOElectra Therapeutics Inc., a clinical-stage developer of immunology drugs, opened at its IPO price on Friday after raising $350 million in an upsized US offering.View original source — Bloomberg ↗ShareCopy linkShare on XShare on FacebookRelated storiesHealthBloombergHealthJun 10, 2026 · 1 minDrugmaker Parabilis Raises $745 Million in US IPO, PlacementBloombergHealthBloombergHealthJun 18, 2026 · 1 minBiotech Kardigan Rises Nearly 2% After $400 Million IPOBloombergBusinessBloombergBusinessSep 15, 2026 · 1 minEclat Health Is Said to Consider $300 Million India IPOBloombergBusinessBloombergBusinessSep 3, 2026 · 1 minSmart Ring Maker Oura Files for US IPO as Revenue SurgesBloomberg
HealthBloombergHealthJun 10, 2026 · 1 minDrugmaker Parabilis Raises $745 Million in US IPO, PlacementBloomberg
HealthBloombergHealthJun 18, 2026 · 1 minBiotech Kardigan Rises Nearly 2% After $400 Million IPOBloomberg
BusinessBloombergBusinessSep 15, 2026 · 1 minEclat Health Is Said to Consider $300 Million India IPOBloomberg
BusinessBloombergBusinessSep 3, 2026 · 1 minSmart Ring Maker Oura Files for US IPO as Revenue SurgesBloomberg